Everand Logo

Welcome to Everand!

  • STAT

    ‘Not a good day for Novartis’: CEO tries to reassure employees amid fury over payments to Trump’s lawyer

    Novartis' CEO sent employees an email Thursday seeking to contain intensifying political and business fallout over the revelation that the drug maker paid $1.2 million to President Trump's personal lawyer…
    by Ed Silverman May 10, 2018 2 minutes
    Former Novartis CEO Joe Jimenez (left) shakes hands with current CEO Vasant Narasimhan during a press conference in Basel, Switzerland, in January.

    The chief executive of Novartis sent employees an email Thursday seeking to contain intensifying political and business fallout over the revelation that the drug maker paid $1.2 million to President Trump’s personal lawyer to gain access to the White House.

    “Yesterday was not a good day for Novartis,” wrote Vasant Narasimhan, a

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A GLP-1 Side Effect, U.K. Clinical Trial Transparency, And More
    A new study links GLP-1 drugs like Ozempic to a higher risk of aspiration pneumonia — a lung infection caused by food breathed into the lungs — after endoscopies.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Drug For Lung Cancer, A Novo Plant Fire, And More
    The FDA approved an innovative treatment from Amgen for patients with small cell lung cancer who have exhausted all other options.
    STAT1 min read
    STAT+: Pharmalittle: We’re Watching BIO Layoffs, AstraZeneca Plans To Double Revenue, And More
    The Biotechnology Innovation Organization on Monday announced 30 layoffs that are part of a restructuring.

    Related Books & Audiobooks